Idiosyncratic drug reactions: the reactive metabolite syndromes (Q34081284)

30 July 2017

title

Idiosyncratic drug reactions: the reactive metabolite syndromes (English)

1 reference

30 July 2017

S R Knowles

1

1 reference

30 July 2017

J Uetrecht

series ordinal

2

1 reference

30 July 2017

N H Shear

series ordinal

3

1 reference

30 July 2017

publication date

1 November 2000

1 reference

30 July 2017

language of work or name

0 references

1 reference

30 July 2017

volume

356

1 reference

30 July 2017

issue

9241

1 reference

30 July 2017

page(s)

1587-1591

1 reference

publication type of scholarly work

30 July 2017

review article

1 reference

Severe adverse cutaneous reactions to drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Lamotrigine-associated anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Familial occurrence of hypersensitivity to phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

In-vitro assessment of a hypersensitivity syndrome associated with sorbinil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

A prospective clinical and immunologic analysis of patients with serum sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Serum sickness-like reactions associated with cefprozil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

1 reference

7 January 2021

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Minocycline-induced Lupus in Adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Sulfamethoxazole is metabolized to the hydroxylamine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Safety of lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

High incidence of a concentration-dependent skin reaction in children treated with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Management of acquired bullous skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Programmed cell death, apoptosis and killer genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

In vivo and in vitro testing for adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinico-pathologic presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

Cefaclor-associated serum sickness-like disease: eight cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903137-8

7 January 2021

10.1016/S0140-6736(00)03137-8

Identifiers

DOI

1 reference

30 July 2017

1 reference